CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Functional and Structural Recovery of the Retina after Gene Therapy in the RPE65 Null Mutation Dog

Narfstro¨m, Kristina, Katz, Martin L., Bragadottir, Ragnheidur, Seeliger, Mathias, Boulanger, Ana, Redmond, T. Michael, Caro, Lynette, Lai, Chooi-May, Rakoczy, P. Elizabeth · 2003 · Investigative Opthalmology & Visual Science

Abstract

PURPOSE: To assess the efficacy of AAV-mediated gene therapy to restore vision in a large number of RPE65(-/-) dogs and to determine whether systemic and local side effects are caused by the treatment. METHODS: Normal RPE65 dog cDNA was subcloned into an rAAV vector under control of a cytomegalovirus promoter, and an AAV.GFP control vector was also produced with the titers 2 x 10(12) particles/mL and 2 x 10(10) transducing U/mL, respectively. RPE65(-/-) dogs, aged 4 to 30 months were treated with subretinal injections of the AAV.RPE65 and control vectors, respectively, in each eye, and three 24- to 30-month-old normal control dogs with the latter. Baseline and postoperative systemic and ophthalmic examinations, blood screenings, vision testing, and electroretinography (ERG) were performed. Two RPE65(-/-) dogs were killed at 3 and 6 months after treatment for morphologic examination of the retinas. RESULTS: RPE65(-/-) dogs were practically blind from birth with nonrecordable or low-amplitude ERGs. Construct injections or sham surgeries were performed in 28 eyes; 11 were injected subretinally with the AAV.RPE65 construct. ERGs at 3 months after surgery showed that in the latter eyes, dark-adapted b-wave amplitudes recovered to an average of 28% of normal, and light adapted b-wave amplitudes to 32% of normal. ERG amplitudes were not reduced during a 6- to 9-month follow-up. No systemic side effects were observed, but uveitis developed in nine AAV.RPE65-treated eyes. No uveitis was observed in the eyes treated with the control vector. Immunocytochemistry showed expression of RPE65 in the retinal pigment epithelium (RPE) of AAV.RPE65-treated eyes. Fluorescence microscopy showed expression of green fluorescent protein (GFP) in the RPE and, to a lesser extent, in the neural retinas of AAV.GFP-treated eyes. Ultrastructurally, a reversal of RPE lipid droplet accumulation was observed at the AAV.RPE65 transgene injection site, but not at the site of injection of the control vector. CONCLUSIONS: In 10 of 11 treated RPE65(-/-) eyes, gene transfer resulted in development of vision, both subjectively apparent by loss of nystagmus, and objectively recorded by ERG. Structurally, there was reversal of lipid droplet accumulation in the RPE. Uveitis developed in 75% of the transgene-treated eyes, a complication possibly due to an immunopathogenic response to the RPE65 molecule.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.02-0595

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 22 · Cited by 252

Metadata

Authors
Narfstro¨m, K., Katz, M. L., Bragadottir, R., Seeliger, M., Boulanger, A., Redmond, T. M., Caro, L., Lai, C.-M., & Rakoczy, P. E.
Affiliations
  • From the Vision Science Group, Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, and the
  • University of Missouri (US)
  • Department of Ophthalmology, Ulleval University Hospital, Oslo, Norway; the
  • Universitätsklinikum Tübingen (DE)
  • National Institutes of Health (US)
  • The University of Western Australia (AU)
Venue
Investigative Opthalmology & Visual Science
Published
2003-04-01
Volume
44
Issue
4
Pages
1663
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2139489264
Cited by
252
References
22
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 9 · 2016: 6 · 2015: 10 · 2014: 17 · 2013: 9 · 2012: 11
FWCI
8.96
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Funders
University of Missouri
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
gene therapy, adeno-associated virus vectors, subretinal injection, retinal pigment epithelium, retinitis pigmentosa, electroretinogram, uveitis, visual recovery, canine model, cytomegalovirus promoter, retinal ultrastructure, immunocytochemistry, GFP expression, systemic side effects
MeSH terms
Dependovirus, Animals, Dark Adaptation, Dog Diseases, Dogs, Electroretinography, Eye Proteins, Female, Genetic Vectors, Indicators and Reagents, Luminescent Proteins, Male, Mutation, Night Blindness, Pigment Epithelium of Eye, Proteins, Retina, Retinal Degeneration, Uveitis, Vision Tests, Genetic Therapy, Gene Transfer Techniques, Green Fluorescent Proteins, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Functional and Structural Recovery of the Retina after Gene Therapy in the RPE65 Null Mutation Dog. https://app.cochat.ai/papers/10.1167/iovs.02-0595
The paper
Narfstro¨m, K., Katz, M. L., Bragadottir, R., Seeliger, M., Boulanger, A., Redmond, T. M., Caro, L., Lai, C.-M., & Rakoczy, P. E. (2003). Functional and Structural Recovery of the Retina after Gene Therapy in the RPE65 Null Mutation Dog. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.02-0595

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.